Doravirine Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 100 mg
Reference Brands: Pifeltro (USA/EU)
Category:
Anti Viral
Doravirine is available in Tablets
and strengths such as 100 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Doravirine is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Doravirine can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Doravirine, sold under the brand name Pifeltro, is a non-nucleoside reverse transcriptase inhibitor (NNRTI) developed by Merck & Co. for the treatment of HIV-1 infection in adults. It works by non-competitively inhibiting the HIV-1 reverse transcriptase enzyme, which blocks viral replication and reduces the viral load in the body. Doravirine is used as part of combination antiretroviral therapy to help improve immune system function and manage HIV/AIDS effectively.
This medication is administered orally as 100 mg tablets and is generally well tolerated, with a favorable safety profile compared to older NNRTIs. Doravirine’s effectiveness, combined with its once-daily dosing, makes it a convenient and essential option for long-term HIV management. By reducing HIV-1 replication, it helps prevent disease progression and supports overall health in infected individuals. Pifeltro is available in multiple regions including the USA, EU, and UK, ensuring access to high-quality HIV treatment globally.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing